Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial

By sjmartinez • December 16, 2022

Podolanczuk AJ, Kim JS, Cooper CB, Lasky JA, Murray S, Oldham JM, Raghu G, Flaherty KR, Spino C, Noth I, Martinez FJ; PRECISIONS Study Team. Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial. BMC Pulm Med. 2022 Dec 13;22(1):475. doi: 10.1186/s12890-022-02281-8. PMID: 36514019; PMCID: PMC9746571.

Tags: Clinical Trial, IPF, N-acetylcysteine, protocol, Publications, Pulmonary, Critical Care & Sleep Medicine

Optimizing phage-antibiotic combinations: impact of administration order against daptomycin non-susceptible (DNS) MRSA clinical isolates

Bleick CR, Van Helden SR, Berti AD, Richa R, Lehman SM, Bayer AS, Rybak MJ. Optimizing phage-antibiotic combinations: impact of administration order against daptomycin non-susceptible[...]

Alterations in Resident Immune Cells in Prenatal Trisomy 21 Lungs

Frauenpreis A, Bhattacharya S, Belgacemi R, Sokolskiy P, Deutsch G, Jendzjowsky N, Glass IA, Mariani TJ, Al Alam D, Danopoulos S. Alterations in Resident Immune[...]

Kinetics and concentrations of circulating 25-hydroxyvitamin D using different vitamin D repletion regimens

Babalyan V, Hutchings N, Baghdasaryan S, Qefoyan M, Kara-Poghosyan S, Nannipieri F, Battaglia S, Solfanelli L, Varzhapetyan A, Dallakyan G, Bilezikian JP. Kinetics and concentrations[...]